Quantitative somatostatin receptor image assessment for survival prediction: a full-body, longitudinal, individual lesion analysis of neuroendocrine tumors in patients treated with peptide receptor radiation therapy

被引：0
|
作者：
Santoro-Fernandes, V. [1 ]
Schott, B. [1 ]
Deatsch, A. [1 ]
Keigley, Q. [2 ]
Francken, T. [1 ]
Meeker, R. [1 ]
Lyer, R. [3 ]
Christos, F. [3 ]
Perlman, S. [2 ,4 ]
Jeraj, R. [1 ,4 ]
机构：
[1] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Wisconsin, Sect Nucl Med & Mol Imaging, Dept Radiol, Sch Med & Publ Hlth, Madison, WI USA
[3] Roswell Pk Comprehens Canc Ctr, Div GI Med, Dept Med, Buffalo, NY USA
[4] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-676
引用
收藏
页码：S314 / S315
页数：2
相关论文
共 50 条
  • [31] Survival outcomes of patients treated with hypofractionated stereotactic body radiation therapy for parotid gland tumors: a retrospective analysis
    Karam, Sana D.
    Snider, James W.
    Wang, Hongkun
    Wooster, Margaux
    Lominska, Christopher
    Deeken, John
    Newkirk, Kenneth
    Davidson, Bruce
    Harter, K. William
    FRONTIERS IN ONCOLOGY, 2012, 2 : 1 - 6
  • [32] ASO Visual Abstract: Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors
    Borbon, Luis C.
    Sherman, Scott K.
    Breheny, Patrick J.
    Chandrasekharan, Chandrikha
    Menda, Yusuf
    Bushnell, David
    Bellizzi, Andrew M.
    Ear, Po H.
    O'Dorisio, M. Sue
    O'Dorisio, Thomas M.
    Dillon, Joseph S.
    Howe, James R.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 1193 - 1194
  • [33] Effect of Lutetium-177 Dota Octreotate Peptide Receptor Radionuclide Therapy in Patients With Advanced Neuroendocrine Tumors and Carcinoid Syndrome Refractory to Somatostatin Analogues
    Koffas, Apostolos
    Popat, Rickin
    Demetriou, George
    Quigley, Ann-Marie
    Navalkissoor, Shaunak
    Caplin, Martyn
    Toumpanakis, Christos
    GASTROENTEROLOGY, 2016, 150 (04) : S208 - S208
  • [34] Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (vol 20, pg 1, 2018)
    Werner, Rudolf A.
    Ilhan, Harun
    Lehner, Sebastian
    Papp, Laszlo
    Zsoter, Norbert
    Schatka, Imke
    Muegge, Dirk O.
    Javadi, Mehrbod S.
    Higuchi, Takahiro
    Buck, Andreas K.
    Bartenstein, Peter
    Bengel, Frank
    Essler, Markus
    Lapa, Constantin
    Bundschuh, Ralph A.
    MOLECULAR IMAGING AND BIOLOGY, 2018, 20 (06) : 1068 - 1068
  • [35] MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy
    Gujarathi, Rushabh
    Abou Azar, Sara
    Tobias, Joseph
    Polite, Blase N.
    Setia, Namrata
    Feinberg, Nicholas
    Appelbaum, Daniel E.
    Keutgen, Xavier M.
    Liao, Chih-Yi
    ENDOCRINE-RELATED CANCER, 2024, 31 (11)
  • [36] Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE
    Pretot, Dominique
    Engel-Bicik, Ivette
    Kenkel, David
    Kaufmann, Philipp A.
    Treyer, Valerie
    Siebenhuner, Alexander R.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (03) : 1204 - 1217
  • [37] Longterm outcome of peptide receptor radionuclide therapy (PRRT) in 454 patients with progressive neuroendocrine tumors using yttrium-90 and lutetium-177 labelled somatostatin receptor targeting peptides
    Hoersch, D.
    Prasad, V.
    Baum, R. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Intestinal obstruction in patients receiving peptide receptor radionuclide therapy for gastroentero-pancreatic neuroendocrine tumors: potential predictors and association with overall survival
    Badawy, Mohamed
    Johnson, Geoffrey
    Wee, Christopher
    Halfdanarson, Thorvardur R.
    Abdelrazek, Ahmad
    Packard, Ann
    Jain, Manoj
    Thorpe, Matthew
    Kendi, Ayse
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [39] Safety and Effectiveness of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy After Regional Hepatic Embolization in Patients With Somatostatin-Expressing Neuroendocrine Tumors
    Hamiditabar, Mohammadali
    Ali, Muzammil
    Bolek, Luke
    Vahdati, Gelareh
    Tworowska, Izabela
    Delpassand, Ebrahim S.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (11) : 822 - 828
  • [40] Patients with Advanced Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy with 177Lu-DOTATE: Data from Spanish SEPTRALU Registry
    Mitjavila, M.
    Percovich, J. C.
    Pombo Pasin, M. C.
    Bello, P.
    Arbizu, J.
    Llana, B.
    Riesco, M. C.
    Muros, M. A.
    Estenoz, J.
    Rotger, A.
    Aller, J.
    Jimenez-Fonseca, P.
    NEUROENDOCRINOLOGY, 2019, 108 : 223 - 223
12345